Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bipolar Disorder | 105 | 2023 | 5124 | 6.940 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 72 | 2024 | 3742 | 3.240 |
Why?
|
Conduct Disorder | 15 | 2023 | 245 | 3.030 |
Why?
|
Antipsychotic Agents | 19 | 2022 | 3077 | 1.380 |
Why?
|
Psychiatric Status Rating Scales | 41 | 2022 | 6035 | 1.280 |
Why?
|
Central Nervous System Stimulants | 7 | 2023 | 1180 | 1.210 |
Why?
|
Psychiatry | 5 | 2024 | 1714 | 1.200 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 12 | 2023 | 306 | 1.190 |
Why?
|
Siblings | 7 | 2015 | 829 | 1.140 |
Why?
|
Antimanic Agents | 12 | 2022 | 524 | 1.090 |
Why?
|
Telemedicine | 6 | 2023 | 3104 | 0.990 |
Why?
|
Inositol | 4 | 2022 | 216 | 0.990 |
Why?
|
Child | 127 | 2024 | 80863 | 0.970 |
Why?
|
Antisocial Personality Disorder | 4 | 2023 | 224 | 0.960 |
Why?
|
Family | 9 | 2019 | 3208 | 0.950 |
Why?
|
Child Behavior Disorders | 5 | 2022 | 813 | 0.830 |
Why?
|
Child Development Disorders, Pervasive | 9 | 2014 | 600 | 0.830 |
Why?
|
Comorbidity | 51 | 2024 | 10601 | 0.790 |
Why?
|
Adolescent | 108 | 2024 | 89168 | 0.780 |
Why?
|
Psychopharmacology | 4 | 2024 | 146 | 0.780 |
Why?
|
Risperidone | 7 | 2022 | 383 | 0.740 |
Why?
|
Irritable Mood | 7 | 2017 | 196 | 0.730 |
Why?
|
Mental Health Services | 3 | 2023 | 1732 | 0.720 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 14 | 2017 | 1994 | 0.670 |
Why?
|
Catatonia | 1 | 2022 | 181 | 0.630 |
Why?
|
Euphoria | 2 | 2017 | 65 | 0.630 |
Why?
|
Affective Symptoms | 4 | 2018 | 418 | 0.570 |
Why?
|
Fatty Acids, Omega-3 | 2 | 2022 | 1398 | 0.560 |
Why?
|
Checklist | 8 | 2022 | 843 | 0.560 |
Why?
|
Aggression | 6 | 2023 | 750 | 0.520 |
Why?
|
Benzodiazepines | 6 | 2022 | 1139 | 0.510 |
Why?
|
Videoconferencing | 1 | 2017 | 207 | 0.480 |
Why?
|
Anxiety Disorders | 12 | 2014 | 2754 | 0.480 |
Why?
|
Family Health | 4 | 2013 | 1256 | 0.470 |
Why?
|
Psychotic Disorders | 6 | 2022 | 3278 | 0.460 |
Why?
|
Asymptomatic Diseases | 1 | 2017 | 591 | 0.450 |
Why?
|
Adolescent Psychiatry | 3 | 2024 | 160 | 0.410 |
Why?
|
Child Psychiatry | 4 | 2024 | 231 | 0.410 |
Why?
|
Disease Susceptibility | 2 | 2019 | 1797 | 0.400 |
Why?
|
Gyrus Cinguli | 4 | 2012 | 1136 | 0.400 |
Why?
|
Piperazines | 4 | 2022 | 2546 | 0.400 |
Why?
|
Book Reviews as Topic | 1 | 2011 | 4 | 0.400 |
Why?
|
Interview, Psychological | 9 | 2013 | 812 | 0.390 |
Why?
|
Eicosapentaenoic Acid | 1 | 2015 | 563 | 0.380 |
Why?
|
Humans | 149 | 2024 | 768451 | 0.370 |
Why?
|
Anticonvulsants | 7 | 2011 | 1923 | 0.360 |
Why?
|
Male | 106 | 2022 | 364781 | 0.340 |
Why?
|
Obstetric Labor Complications | 1 | 2012 | 243 | 0.340 |
Why?
|
Pediatrics | 3 | 2010 | 3622 | 0.330 |
Why?
|
Hypericum | 1 | 2009 | 58 | 0.320 |
Why?
|
Docosahexaenoic Acids | 1 | 2015 | 907 | 0.320 |
Why?
|
Acupuncture | 1 | 2009 | 90 | 0.310 |
Why?
|
Female | 100 | 2022 | 396943 | 0.310 |
Why?
|
Depressive Disorder | 9 | 2014 | 3738 | 0.300 |
Why?
|
Age of Onset | 14 | 2014 | 3342 | 0.300 |
Why?
|
Cystic Fibrosis | 1 | 2017 | 1287 | 0.300 |
Why?
|
Triazines | 1 | 2010 | 312 | 0.300 |
Why?
|
Depressive Disorder, Major | 9 | 2013 | 4816 | 0.290 |
Why?
|
Thiazoles | 2 | 2022 | 1541 | 0.290 |
Why?
|
S-Adenosylmethionine | 1 | 2009 | 220 | 0.290 |
Why?
|
Fructose | 1 | 2009 | 285 | 0.290 |
Why?
|
Prospective Studies | 21 | 2022 | 54914 | 0.280 |
Why?
|
Cognition Disorders | 6 | 2011 | 3985 | 0.270 |
Why?
|
Mood Disorders | 7 | 2010 | 1128 | 0.270 |
Why?
|
Quinolones | 2 | 2007 | 382 | 0.270 |
Why?
|
Case-Control Studies | 18 | 2019 | 22293 | 0.270 |
Why?
|
Severity of Illness Index | 14 | 2018 | 15965 | 0.270 |
Why?
|
Mother-Child Relations | 1 | 2009 | 501 | 0.240 |
Why?
|
Neuropsychological Tests | 9 | 2012 | 7134 | 0.230 |
Why?
|
Psychotropic Drugs | 4 | 2017 | 888 | 0.230 |
Why?
|
Pilot Projects | 6 | 2022 | 8730 | 0.230 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 3 | 2012 | 419 | 0.220 |
Why?
|
Diagnosis, Differential | 16 | 2017 | 13026 | 0.220 |
Why?
|
Melatonin | 1 | 2009 | 669 | 0.220 |
Why?
|
Child, Preschool | 21 | 2022 | 42623 | 0.210 |
Why?
|
Parents | 3 | 2021 | 3596 | 0.210 |
Why?
|
Lithium Carbonate | 4 | 2011 | 179 | 0.200 |
Why?
|
Evaluation Studies as Topic | 3 | 2010 | 1629 | 0.200 |
Why?
|
Massachusetts | 8 | 2017 | 8908 | 0.190 |
Why?
|
Genetic Predisposition to Disease | 12 | 2015 | 18048 | 0.190 |
Why?
|
Risk Assessment | 4 | 2019 | 24311 | 0.180 |
Why?
|
Double-Blind Method | 6 | 2022 | 12450 | 0.180 |
Why?
|
Carbamazepine | 4 | 2011 | 224 | 0.180 |
Why?
|
Acetylcysteine | 1 | 2022 | 262 | 0.180 |
Why?
|
Personality Assessment | 5 | 2010 | 649 | 0.180 |
Why?
|
Prevalence | 8 | 2018 | 15880 | 0.170 |
Why?
|
Psychometrics | 8 | 2020 | 3072 | 0.170 |
Why?
|
Drug Therapy, Combination | 6 | 2015 | 6320 | 0.170 |
Why?
|
Health Facility Environment | 1 | 2019 | 32 | 0.170 |
Why?
|
Valproic Acid | 4 | 2011 | 443 | 0.170 |
Why?
|
Mental Disorders | 8 | 2020 | 6879 | 0.160 |
Why?
|
Mothers | 1 | 2009 | 2210 | 0.150 |
Why?
|
Buspirone | 1 | 2018 | 80 | 0.150 |
Why?
|
Clonidine | 2 | 1996 | 170 | 0.150 |
Why?
|
Pregnancy Complications | 1 | 2012 | 2969 | 0.150 |
Why?
|
Methylphenidate | 2 | 2019 | 491 | 0.150 |
Why?
|
Referral and Consultation | 7 | 2018 | 3629 | 0.140 |
Why?
|
Gonadal Hormones | 1 | 2017 | 30 | 0.140 |
Why?
|
Follow-Up Studies | 10 | 2022 | 39430 | 0.140 |
Why?
|
Longitudinal Studies | 8 | 2019 | 14766 | 0.140 |
Why?
|
Quality of Life | 2 | 2022 | 13497 | 0.140 |
Why?
|
Young Adult | 16 | 2022 | 60045 | 0.140 |
Why?
|
Age Factors | 14 | 2018 | 18478 | 0.140 |
Why?
|
Cross-Cultural Comparison | 2 | 2011 | 639 | 0.130 |
Why?
|
Sympatholytics | 1 | 1996 | 82 | 0.130 |
Why?
|
Adult | 26 | 2023 | 223542 | 0.130 |
Why?
|
Social Behavior Disorders | 1 | 2016 | 101 | 0.130 |
Why?
|
Memantine | 1 | 2016 | 111 | 0.120 |
Why?
|
Glutamic Acid | 3 | 2012 | 1192 | 0.120 |
Why?
|
Treatment Outcome | 17 | 2022 | 65409 | 0.120 |
Why?
|
Substance-Related Disorders | 6 | 2016 | 4453 | 0.120 |
Why?
|
Psychology | 2 | 2024 | 356 | 0.120 |
Why?
|
Risk Factors | 18 | 2018 | 74915 | 0.120 |
Why?
|
Educational Status | 1 | 2022 | 2519 | 0.120 |
Why?
|
Brief Psychiatric Rating Scale | 2 | 2018 | 108 | 0.110 |
Why?
|
Safety Management | 1 | 2019 | 764 | 0.110 |
Why?
|
Ambulatory Care | 3 | 2020 | 2780 | 0.110 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2016 | 452 | 0.110 |
Why?
|
Medical History Taking | 1 | 2017 | 776 | 0.110 |
Why?
|
Random Allocation | 1 | 2017 | 2399 | 0.100 |
Why?
|
Colic | 1 | 2012 | 44 | 0.100 |
Why?
|
Pedigree | 3 | 2012 | 4545 | 0.100 |
Why?
|
Child Behavior | 4 | 2022 | 862 | 0.100 |
Why?
|
Pandemics | 2 | 2023 | 8753 | 0.100 |
Why?
|
Professional-Patient Relations | 1 | 2017 | 727 | 0.100 |
Why?
|
Cost Savings | 1 | 2017 | 916 | 0.100 |
Why?
|
Dibenzothiazepines | 1 | 2011 | 102 | 0.090 |
Why?
|
Isoxazoles | 1 | 2013 | 233 | 0.090 |
Why?
|
Social Behavior | 3 | 2014 | 1144 | 0.090 |
Why?
|
Ethanol | 1 | 2017 | 1334 | 0.090 |
Why?
|
Clinical Trials as Topic | 3 | 2022 | 8051 | 0.090 |
Why?
|
Obsessive-Compulsive Disorder | 2 | 2010 | 1509 | 0.090 |
Why?
|
Antidepressive Agents | 1 | 2022 | 2913 | 0.090 |
Why?
|
Reproducibility of Results | 5 | 2022 | 20231 | 0.090 |
Why?
|
Emotional Intelligence | 1 | 2011 | 135 | 0.090 |
Why?
|
Academic Medical Centers | 2 | 2019 | 2785 | 0.090 |
Why?
|
Lecithins | 1 | 2009 | 16 | 0.080 |
Why?
|
Sex Factors | 5 | 2017 | 10647 | 0.080 |
Why?
|
Tic Disorders | 2 | 2024 | 140 | 0.080 |
Why?
|
Lithium | 2 | 2005 | 600 | 0.080 |
Why?
|
Autistic Disorder | 3 | 2014 | 1240 | 0.080 |
Why?
|
Child Development | 1 | 2000 | 2328 | 0.080 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2012 | 3783 | 0.080 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2013 | 4636 | 0.080 |
Why?
|
Self Disclosure | 1 | 2009 | 249 | 0.070 |
Why?
|
Anxiety | 2 | 2018 | 4655 | 0.070 |
Why?
|
Lithium Compounds | 1 | 2009 | 226 | 0.070 |
Why?
|
Curriculum | 1 | 2021 | 3778 | 0.070 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2010 | 490 | 0.070 |
Why?
|
Achievement | 1 | 2009 | 288 | 0.070 |
Why?
|
Prolactin | 2 | 2007 | 626 | 0.070 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2009 | 328 | 0.070 |
Why?
|
Catechol O-Methyltransferase | 1 | 2009 | 251 | 0.070 |
Why?
|
Alcoholism | 2 | 2016 | 1993 | 0.070 |
Why?
|
Socioeconomic Factors | 3 | 2005 | 7863 | 0.070 |
Why?
|
Glutamine | 2 | 2006 | 578 | 0.070 |
Why?
|
Drug Administration Schedule | 3 | 2010 | 4861 | 0.070 |
Why?
|
Patient Satisfaction | 1 | 2019 | 3484 | 0.070 |
Why?
|
Social Adjustment | 3 | 2011 | 636 | 0.060 |
Why?
|
Suicide | 1 | 2017 | 1608 | 0.060 |
Why?
|
Genetic Association Studies | 2 | 2012 | 2742 | 0.060 |
Why?
|
Drug Tolerance | 1 | 2007 | 367 | 0.060 |
Why?
|
Risk | 3 | 2016 | 9642 | 0.060 |
Why?
|
Cross-Sectional Studies | 10 | 2019 | 26351 | 0.060 |
Why?
|
Loratadine | 1 | 2005 | 13 | 0.060 |
Why?
|
Histamine H1 Antagonists, Non-Sedating | 1 | 2005 | 17 | 0.060 |
Why?
|
Nuclear Family | 2 | 2009 | 311 | 0.060 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2009 | 607 | 0.060 |
Why?
|
Single-Blind Method | 2 | 2012 | 1585 | 0.060 |
Why?
|
Attitude of Health Personnel | 1 | 2019 | 3922 | 0.060 |
Why?
|
Phenotype | 4 | 2009 | 16712 | 0.060 |
Why?
|
Interpersonal Relations | 1 | 2012 | 1439 | 0.060 |
Why?
|
Sensitivity and Specificity | 3 | 2012 | 14728 | 0.060 |
Why?
|
Health Status | 1 | 2017 | 4096 | 0.060 |
Why?
|
Amphetamine | 1 | 2005 | 224 | 0.060 |
Why?
|
Smoking | 2 | 2016 | 9099 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3116 | 0.050 |
Why?
|
Personality Tests | 1 | 2022 | 80 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2020 | 4877 | 0.050 |
Why?
|
Executive Function | 1 | 2011 | 1402 | 0.050 |
Why?
|
Brain Chemistry | 1 | 2006 | 962 | 0.050 |
Why?
|
Depression | 4 | 2017 | 8235 | 0.050 |
Why?
|
Weight Gain | 2 | 2009 | 2357 | 0.050 |
Why?
|
Psychotherapy | 3 | 2018 | 1656 | 0.050 |
Why?
|
Delayed-Action Preparations | 2 | 2019 | 969 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2019 | 10784 | 0.050 |
Why?
|
Least-Squares Analysis | 1 | 2002 | 368 | 0.050 |
Why?
|
Disease Progression | 3 | 2003 | 13655 | 0.050 |
Why?
|
Psychomotor Performance | 1 | 2009 | 1894 | 0.050 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 4249 | 0.050 |
Why?
|
Cost of Illness | 1 | 2010 | 1960 | 0.040 |
Why?
|
Prognosis | 4 | 2011 | 30028 | 0.040 |
Why?
|
Body Weight | 2 | 2010 | 4630 | 0.040 |
Why?
|
Pyrimidines | 1 | 2013 | 3050 | 0.040 |
Why?
|
Odds Ratio | 1 | 2012 | 9687 | 0.040 |
Why?
|
Social Problems | 1 | 2000 | 109 | 0.040 |
Why?
|
Eosinophils | 1 | 2005 | 955 | 0.040 |
Why?
|
Sex Characteristics | 2 | 2017 | 2666 | 0.040 |
Why?
|
Middle Aged | 10 | 2019 | 223418 | 0.040 |
Why?
|
Nasal Polyps | 1 | 2005 | 409 | 0.040 |
Why?
|
Predictive Value of Tests | 2 | 2020 | 15460 | 0.040 |
Why?
|
Starch | 1 | 2019 | 81 | 0.040 |
Why?
|
Spain | 2 | 2011 | 491 | 0.040 |
Why?
|
Nurse's Role | 1 | 2019 | 188 | 0.040 |
Why?
|
Psychopathology | 1 | 2021 | 435 | 0.040 |
Why?
|
History, 21st Century | 1 | 2024 | 1575 | 0.040 |
Why?
|
Mast Cells | 1 | 2005 | 1407 | 0.040 |
Why?
|
Chi-Square Distribution | 3 | 2011 | 3438 | 0.040 |
Why?
|
Polyesters | 1 | 2019 | 375 | 0.030 |
Why?
|
Genome-Wide Association Study | 3 | 2011 | 12774 | 0.030 |
Why?
|
Recurrence | 3 | 2004 | 8510 | 0.030 |
Why?
|
Risk Management | 1 | 2019 | 558 | 0.030 |
Why?
|
Incidence | 2 | 2012 | 21552 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2005 | 1892 | 0.030 |
Why?
|
Family Relations | 2 | 2011 | 318 | 0.030 |
Why?
|
History, 20th Century | 1 | 2024 | 2772 | 0.030 |
Why?
|
Clomipramine | 1 | 1995 | 54 | 0.030 |
Why?
|
Patient Care Team | 2 | 2019 | 2526 | 0.030 |
Why?
|
Pregnancy | 2 | 2017 | 30179 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2011 | 10358 | 0.030 |
Why?
|
Abnormalities, Drug-Induced | 1 | 2017 | 341 | 0.030 |
Why?
|
Cognition | 1 | 2012 | 7066 | 0.030 |
Why?
|
Creatine | 2 | 2006 | 427 | 0.030 |
Why?
|
Specialization | 1 | 2019 | 782 | 0.030 |
Why?
|
Schools | 1 | 2003 | 1496 | 0.030 |
Why?
|
Anisotropy | 1 | 2017 | 1296 | 0.030 |
Why?
|
Retrospective Studies | 9 | 2018 | 81834 | 0.030 |
Why?
|
Morbidity | 1 | 2018 | 1760 | 0.030 |
Why?
|
Self-Injurious Behavior | 1 | 2019 | 571 | 0.030 |
Why?
|
Advisory Committees | 1 | 2017 | 797 | 0.030 |
Why?
|
Mass Screening | 1 | 2009 | 5455 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3624 | 0.030 |
Why?
|
Logistic Models | 2 | 2011 | 13324 | 0.030 |
Why?
|
Saliva | 1 | 2017 | 854 | 0.030 |
Why?
|
Research Design | 2 | 2011 | 6217 | 0.020 |
Why?
|
Reference Values | 2 | 2016 | 4941 | 0.020 |
Why?
|
Semaphorin-3A | 1 | 2011 | 39 | 0.020 |
Why?
|
Juvenile Delinquency | 1 | 1992 | 116 | 0.020 |
Why?
|
Sick Role | 1 | 1992 | 229 | 0.020 |
Why?
|
Psychology, Social | 1 | 2011 | 52 | 0.020 |
Why?
|
Patient Preference | 1 | 2019 | 948 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 2003 | 2518 | 0.020 |
Why?
|
Sialoglycoproteins | 1 | 2011 | 320 | 0.020 |
Why?
|
Data Collection | 1 | 2019 | 3329 | 0.020 |
Why?
|
Asperger Syndrome | 1 | 2010 | 57 | 0.020 |
Why?
|
Infant | 1 | 2012 | 36497 | 0.020 |
Why?
|
Obsessive Behavior | 1 | 2010 | 51 | 0.020 |
Why?
|
Chronic Disease | 1 | 2004 | 9382 | 0.020 |
Why?
|
Compulsive Behavior | 1 | 2010 | 117 | 0.020 |
Why?
|
Aging | 2 | 2012 | 8761 | 0.020 |
Why?
|
Psychological Tests | 1 | 2011 | 643 | 0.020 |
Why?
|
Sensory Gating | 1 | 2008 | 47 | 0.020 |
Why?
|
Treatment Refusal | 1 | 1992 | 432 | 0.020 |
Why?
|
Analysis of Variance | 2 | 2013 | 6242 | 0.020 |
Why?
|
Probability | 1 | 2014 | 2483 | 0.020 |
Why?
|
Wechsler Scales | 1 | 2008 | 258 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2005 | 7451 | 0.020 |
Why?
|
Databases, Factual | 1 | 2023 | 8081 | 0.020 |
Why?
|
Hospitals, University | 1 | 2009 | 569 | 0.020 |
Why?
|
Consensus | 1 | 2017 | 3207 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 2011 | 798 | 0.020 |
Why?
|
Phobic Disorders | 1 | 2010 | 441 | 0.020 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2009 | 395 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2011 | 12096 | 0.020 |
Why?
|
Registries | 1 | 2023 | 8373 | 0.020 |
Why?
|
California | 1 | 2011 | 1444 | 0.020 |
Why?
|
Ethics, Medical | 1 | 1992 | 785 | 0.020 |
Why?
|
Antidepressive Agents, Tricyclic | 2 | 1999 | 433 | 0.020 |
Why?
|
Diffusion Tensor Imaging | 1 | 2017 | 2427 | 0.020 |
Why?
|
Verbal Learning | 1 | 2008 | 465 | 0.020 |
Why?
|
3' Untranslated Regions | 1 | 2008 | 515 | 0.020 |
Why?
|
Statistics as Topic | 2 | 2005 | 2362 | 0.020 |
Why?
|
Problem Solving | 1 | 2008 | 443 | 0.020 |
Why?
|
Wounds, Gunshot | 1 | 1992 | 589 | 0.020 |
Why?
|
Health Expenditures | 1 | 2019 | 2391 | 0.020 |
Why?
|
Aspartate Aminotransferases | 1 | 2007 | 414 | 0.020 |
Why?
|
Intelligence | 1 | 2011 | 929 | 0.020 |
Why?
|
Body Mass Index | 1 | 2023 | 13030 | 0.020 |
Why?
|
Eosinophil Cationic Protein | 1 | 2005 | 9 | 0.020 |
Why?
|
Phosphocreatine | 1 | 2006 | 261 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 2863 | 0.020 |
Why?
|
Societies, Medical | 1 | 2017 | 3955 | 0.020 |
Why?
|
Exanthema | 1 | 2010 | 504 | 0.020 |
Why?
|
Nerve Net | 1 | 2017 | 2362 | 0.010 |
Why?
|
Alanine Transaminase | 1 | 2007 | 605 | 0.010 |
Why?
|
Age Distribution | 1 | 2010 | 2881 | 0.010 |
Why?
|
Socialization | 1 | 2004 | 88 | 0.010 |
Why?
|
Leukotriene C4 | 1 | 2005 | 79 | 0.010 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2017 | 2538 | 0.010 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2011 | 1628 | 0.010 |
Why?
|
Tryptases | 1 | 2005 | 176 | 0.010 |
Why?
|
Adolescent Behavior | 2 | 2004 | 1192 | 0.010 |
Why?
|
Psychomotor Agitation | 1 | 2006 | 307 | 0.010 |
Why?
|
Placebos | 1 | 2007 | 1668 | 0.010 |
Why?
|
Reaction Time | 1 | 2008 | 2102 | 0.010 |
Why?
|
Memory, Short-Term | 1 | 2008 | 1009 | 0.010 |
Why?
|
Outpatients | 1 | 2010 | 1607 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2006 | 2298 | 0.010 |
Why?
|
United States | 2 | 2000 | 73121 | 0.010 |
Why?
|
Uric Acid | 1 | 2007 | 807 | 0.010 |
Why?
|
Fasting | 1 | 2007 | 1608 | 0.010 |
Why?
|
Serotonin | 1 | 2006 | 1047 | 0.010 |
Why?
|
Linear Models | 1 | 2011 | 5880 | 0.010 |
Why?
|
Protons | 1 | 2006 | 1113 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2010 | 16029 | 0.010 |
Why?
|
Serine Endopeptidases | 1 | 2005 | 1032 | 0.010 |
Why?
|
Hospitals, General | 1 | 2003 | 807 | 0.010 |
Why?
|
Dopamine | 1 | 2006 | 1616 | 0.010 |
Why?
|
Hospitalization | 2 | 2011 | 10845 | 0.010 |
Why?
|
Cholesterol | 1 | 2007 | 2910 | 0.010 |
Why?
|
Attention | 1 | 2008 | 2423 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40271 | 0.010 |
Why?
|
Boston | 1 | 2010 | 9361 | 0.010 |
Why?
|
Cohort Studies | 3 | 2005 | 41797 | 0.010 |
Why?
|
Drug Hypersensitivity | 1 | 2005 | 922 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2003 | 2733 | 0.010 |
Why?
|
Genotype | 1 | 2010 | 13047 | 0.010 |
Why?
|
Regression Analysis | 1 | 2005 | 6353 | 0.010 |
Why?
|
Genetic Variation | 1 | 2010 | 6610 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2005 | 2279 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2011 | 7895 | 0.010 |
Why?
|
Medical Records | 1 | 1998 | 1413 | 0.010 |
Why?
|
Aspirin | 1 | 2005 | 3139 | 0.010 |
Why?
|
Blood Glucose | 1 | 2007 | 6429 | 0.010 |
Why?
|
Clinical Protocols | 1 | 1998 | 1444 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2012 | 36840 | 0.010 |
Why?
|
Family Therapy | 1 | 1992 | 214 | 0.010 |
Why?
|
Aged | 2 | 2019 | 171520 | 0.010 |
Why?
|
Brain | 1 | 2017 | 27438 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2000 | 12561 | 0.000 |
Why?
|
Survival Analysis | 1 | 1998 | 10125 | 0.000 |
Why?
|
Physician's Role | 1 | 1992 | 927 | 0.000 |
Why?
|
Obesity | 1 | 2007 | 13065 | 0.000 |
Why?
|